PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.
经患健侧上肢贵要
脉、肘正中
脉将PICC导管置入上
脉进行化疗。
PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.
经患健侧上肢贵要
脉、肘正中
脉将PICC导管置入上
脉进行化疗。
The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.
讨论了病例选择,淋巴结廓清,支气管和肺管处理,以及上
脉替换和修补。
Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.
结果全组患无手
死亡,
上
脉梗阻症状均明显改善。1例
人造
管
栓形成,经溶栓治疗
痊愈。全组患
存活时间为6~30个月。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.
经健侧上肢贵要
、肘正中
将PICC导管置入上腔
进行化疗。
The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.
讨论了病例选择,淋巴结廓清,支气管和肺管处理,以及上腔
替换和修补。
Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.
结果全无手术死亡,术后上腔
梗阻症状均明显改善。1例术后人造
管
栓形成,经溶栓治疗后痊愈。全
术后存活时间为6~30个月。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.
经患者健侧上肢贵要静脉、肘正中静脉将PICC导管置入上腔静脉进行化疗。
The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.
讨论了病例,
巴结廓清,支气管
肺
管处理,以及上腔静脉
修补。
Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.
结果全组患者无手术死亡,术后上腔静脉梗阻症状均明显改善。1例术后人造管
栓形成,经溶栓治疗后痊愈。全组患者术后存活时间为6~30个月。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.
经患者健侧上肢贵要静脉、肘正中静脉将PICC导置入上腔静脉进行化疗。
The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.
讨论了病例选择,淋巴结廓清,支气,以及上腔静脉替换
修补。
Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.
结果全组患者无手术死亡,术后上腔静脉梗阻症状均明显改善。1例术后人造栓形成,经溶栓治疗后痊愈。全组患者术后存活时间为6~30个月。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.
经者健侧上肢贵要静脉、肘正中静脉将PICC导管置入上腔静脉进行
。
The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.
论了病例选择,淋巴结廓清,支气管和肺
管处理,以及上腔静脉替换和修补。
Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.
结果者无手术死亡,术后上腔静脉梗阻症状均明显改善。1例术后人造
管
栓形成,经溶栓治
后痊愈。
者术后存活时间为6~30个月。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.
经患者健侧肢贵要静脉、肘正中静脉将PICC导管
腔静脉进行化疗。
The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.
讨论了病例选择,淋巴结廓清,支气管和肺管处理,以及
腔静脉替换和修补。
Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.
结果全组患者无手死
,
腔静脉梗阻症状均明显改善。1例
人造
管
栓形成,经溶栓治疗
痊愈。全组患者
存活时间为6~30个月。
声明:以例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.
经患者健侧肢贵要静脉、肘正中静脉将PICC导管置
静脉进行化疗。
The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.
讨论了病例选择,淋巴结廓清,支气管和肺管处理,以及
静脉替换和修补。
Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.
结果全组患者无手,
后
静脉梗阻症状均明显改善。1例
后人造
管
栓形成,经溶栓治疗后痊愈。全组患者
后存活时间为6~30个月。
声明:以例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.
经患者健侧上肢贵要静脉、肘正中静脉将PICC导管置入上腔静脉进行化疗。
The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.
讨论了病例选择,淋巴结廓清,支气管和肺管处理,以及上腔静脉替换和修补。
Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.
结果全组患者无手术死亡,术后上腔静脉梗阻症状均明显改善。1例术后人造管
栓形成,经溶栓治疗后痊愈。全组患者术后存活时间
6~30
。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.
经患者健侧上静脉、肘正中静脉将PICC导管置入上腔静脉进行化疗。
The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.
讨论了病例选择,淋巴结廓清,支气管和肺管处理,以及上腔静脉替换和修补。
Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.
结果全组患者无手术死亡,术后上腔静脉梗阻症状均明。1例术后人造
管
栓形成,经溶栓治疗后痊愈。全组患者术后存活时间为6~30个月。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。